Picture of Abcam logo

ABC Abcam Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+4.04%
3m+10.46%
6m-0.8%
1yr-15.99%
Volume Change (%)
10d/3m-34.34%
Price vs... (%)
52w High-28.52%
50d MA+5.44%
200d MA-6.72%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)38.56
PEG Ratio (f)2.14
EPS Growth (f)21.96%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.39
Price to Tang. Book50.45
Price to Free Cashflow242.06
Price to Sales6.22
EV to EBITDA37.04

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital3.05%
Return on Equity2.68%
Operating Margin5.27%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue£m233.2259.9260297.7462.9380429.2816.35%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+84.8-15.35-31.45-46.31+96.46+11.08+27.79n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Abcam EPS forecast chart

Profile Summary

Abcam plc is a United Kingdom-based life science company. The Company is engaged in the identification, development and distribution of biological reagents. The Company’s products are used by various researchers worldwide to study biological pathways critical for scientific research, diagnostics and drug discovery. Its products can be grouped into two categories: research use only (RUO) proteomic tools and antibodies for clinical application. RUO products include protein binding reagents, such as antibodies and immunoassays, and related reagents. Its RUO products are used to detect, quantify, visualize and modify proteins in scientific research experiments, serving as vital tools to enable its customers to develop insights about targets and biological pathways of interest. Antibodies are a core component of many in vitro diagnostic assays and can also be used as therapeutic agents to treat various diseases, including cancer.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
February 12th, 1998
Public Since
November 3rd, 2005
No. of Employees
1,750
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
228,978,653
Blurred out image of a map
Address
Discovery Drive, CAMBRIDGE, CB20AX
Web
http://www.abcam.com/
Phone
+44 1223696000
Auditors
PricewaterhouseCoopers LLP

ABC Share Price Performance

Latest News for ABC

Upcoming Events for ABC

Similar to ABC

Picture of Alliance Pharma logo

Alliance Pharma

gb flag iconLondon Stock Exchange

Picture of Animalcare logo

Animalcare

gb flag iconLondon Stock Exchange

Picture of AstraZeneca logo

AstraZeneca

gb flag iconLondon Stock Exchange

Picture of Benchmark Holdings logo

Benchmark Holdings

gb flag iconLondon Stock Exchange

Picture of Beximco Pharmaceuticals logo

Beximco Pharmaceuticals

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email